3AM News From China NIO..57.00..Electric Vehicles Nio delivered 7,225 Vehicles in Jan...2021 increasing by 352% year-over-year. Market Cap 88 Billion Assets 5 Billion...Debt 1 Billion StockTA Bullish Short Very Bullish Long Barchart Strong Buy Tip Ranks Buy with Target price 65.28
News Just Out Nintendo..72.27 Nintendo raises outlook after surpassing high expectations Operating Profits 229 Billion Far Exceeding Estimates of 189 Billion
Ground Floor Opportunity HQGE....0007 HQ Global Education parent Company of Big M Entertainment Pictures Last Thursday announced Big M Entertainment Pictures added a new feature film to it's already slate of projects in various stages of production.
RIGL...3.73..Rigel Pharmaceuticals..Developes small-molecule drugs for autoimmune, cancer-related and viral diseases Friday Rigel announced it had been awarded 16.5 Million by US Dept. Of Defense to support Rigels ongoing Phase 3 Clinical Trial to eveluate the safety and efficacy of Fostamatinib in Hospitalized Covid-19 Patients. Market Cap 615 million Held by 201 Institutions owning 86% of Shares Investor Observor Rates it 83 out of 100 Undervalued Cash 72 million..Cash Burn 47 million Short term Assets exceed Short and Long term liabilities Assets 123 million..Debt 10 million Projected to grow 48% over next three months Holding 5.19-5.97 Expected to grow 26% per year StockTA Bullish long and A Barchart Strong Buy Tip Ranks Moderate Buy with Target price 8.00
News Out From China 2AM Li..Electric Vehicles.. Innovator in China"s Electric Vehicle Market delivered 5,379 Vehicles..355% increase year over year Closed 32.04 Market Cap 28 Billion Short term Assets exceeds Short and Long term Liabilities Assets 3 Billion Debt 310 Million Tip Ranks Strong Buy with Target price of 43.64
Could Continue Run DVAX..Up 63% Monday ...10.27 Announced yesterday plans for Phase 2/3 Clinical Study of Clover's S-Trimer Covid-19 Vaccine
ACAC..11.41 Yesterday announced Merger Agreement with PlayStudios an award winning free-to-play casual games for for Mobile and Social Platforms
News Just Out VRNA...8.53 Bio-Pharm focusing on Respiratory Diseases Received positive Phase 2 Data with pressurized dose of ensifentrine in patients with moderate to severe chronic obstructive pulmonary disease Market Cap 409 million LOW FLOAT 13 million Assets 24.5 million Debt 1.4 million StockTA Bullish Short and Long A Barchart Strong Buy Tip Ranks Moderate Buy with Target price of 25.00
News Just Out DMS..10.29 Acquired Aimtell to enhance it's Industry leading Digital Media Distribution Capabilities
EARNINGS BEN..Franklin Resources...26.58 Quarter ending December 31 345 Million...Compared to 75 Million the previous Quarter Merging with Legg Mason contributing to growing success
DVAX...Dipping 15% to great entry range of 8.40 Yesterday came out with news of Clinical Trial of Covid Candidate Analysts still have Target price of 16.00
News at 1AM LNVGY...Lenova Group...Global Tech Hardware..25.08 Second consecutive record-breaking quarter..Group revenue up 22% year on year of 17.2 Billion Quarterly pre-tax income 591 Million up 52% year on year Assets 35 Billion Debt 6 Billion Expected to grow 91% over next three months Growth Prospect rated A Momentum rated A Zacks Number 2 Buy Barchart Strong Buy
News at 2 AM SNE..Sony Corporation...99.24 Sony Boosts Forecast as Profit Smash Estimates Sony launched PlayStation 5 sold 4.5 Million Units taking it to 47.4 Million Sony on track to meet it's goal of surpassing preceeding PlayStation 4's 7.6 Million Sales by end of March
News at 3AM TLSA...Tiziana Life Sciences...4.54 Up yesterday ..On Positive Results of Drug Foralumab Covid-19 Spray Lead Scientist described process.... Enters through the nasal and respiratory passages and the nasal delivery modulates immunity expecting to delay progression of disease and to provide immediate relief to Covid-19 Patients.. Expect a bounce up also today.
Just Out News From London GSK..GlaxoSmithKline..37.59 GlaxoSmithKline and CureVac announced a new 150 Million collaboration to jointly develop next generation mRNA Vaccines for Covid-19 with the potential for a multi-valent approach to address multiple Emergin Variants in One Vaccine GSK will support 100Million Doses of CureVac's Vaccine Candidate CVnCoc in 2021
